TP53 clonal evolution is key to the current understanding of the pathogenesis of high-grade serous ovarian cancer as an evolutionary process initiated from TP53-mutant cells in the fallopian tube (40). The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.